Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2014; 60(4): 56-60


The blood leptin and the activity of the system inflammatory response in patients with diabetes mellitus type 2 with different body weight and disease duration

Man'kovs'kyĭ BM, Urbanovych AM

    Lviv Medical University, Lviv, Ukraine
DOI: https://doi.org/10.15407/fz60.04.056

Abstract

Recent studies focused on the adipose tissue hormones role, especially leptin as one of the basic and generalized nonspecific inflammation markers among them. Some of the major markers are IL-2, IL -6 and TNF-б, in the pathogenesis of diabetes (DM) and its complications. It is established that patients with type 2 diabetes lasting from 5 to 10 years represent the highest leptin and cytokines levels, and during this period cardiovascular complications of type 2 diabetes are formed. Also it is found that the leptin level was significantly lower in patients with normal body weight, while the levels of IL-6 and TNF-б are the highest in these patients. Obviously, the increased level of these cytokines helps to maintain a normal body weight in these patients. Despite the fact that type 2 diabetes is considered a non-autoimmune disease, it is known that for a long glucose toxicity and lipotoxicity metabolic immunosuppression occurs, which causes changes in T-cell immunity, and consequently to autoimmunity.

Keywords: diabetes mellitus, leptin, interleicin.

References

  1. Donath MY., Shoelson SE. Type 2 diabetes as an inflammatory dis'ease. Nat. Rev. Immunol. 2011;11(2):98-07. CrossRef PubMed
  2.  
  3. Herder C, Haastert B, Muller'Scholze S. Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabet. 2005;54(2):11-7. CrossRef  
  4. Su SC, Pei D, Hsieh CH. Circulating proinflammatory cytokines and adiponectin in young men with type 2 diabetes. Acta Diabetol. 2011;48(2):113-19. CrossRef PubMed
  5.  
  6. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-01. CrossRef PubMed PubMedCentral
  7.  
  8. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008; 14 (3-4): 222-31. CrossRef PubMed PubMedCentral
  9.  
  10. Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: Exploring the connection. Arterioscler Thromb Vasc Biol. 2007; 27: 996-03. CrossRef PubMed
  11.  
  12. Maruyama I., Nakata M., Yamaji K. Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann.NY Acad. Sci. 2000; 902: 315-9. CrossRef PubMed
  13.  
  14. Soppack S. W. Pro-inflammatory cytokines and adipose tissue. Proc. Nutr. Soc. 2001; 60:349-56. CrossRef  
  15. Sopasakis VR, Sandqvist M, Gustafson B. High local concentrations and effects on differentiation implicate interleukin- 6 as a paracrine regulator. Obes. Res. 2004;12:454-60. CrossRef PubMed
  16.  
  17. Kopitsa NP. TNF-?: impact on the incidence of recurrent myocardial infarction and sudden cardiac death. Zaporoz Med J. 2004; 3(24):14-6. [Russian].
  18.  
  19. Volkov VI, Strona VI. Diseases of the cardiovascular system in women. Kyiv: Chetverta hvylya; 2011. [Russian]. Arhipova SV, Zorin NA, Yankin MY. The levels of cytokines and acute phase reactants of inflammation in myocardial infarction in men. Clinicheskaya Medicina. 2009;12:20-7. [Russian].
  20. Arhipova SV, Zorin NA, Yankin MY. The levels of cytokines and acute phase reactants of inflammation in myocardial infarction in men. Clinicheskaya Medicina. 2009;12:20-7. [Russian].
  21.  
  22. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor: direct role in obesity - linked insulin resistance. Science. 1993; 259:87 - 91. CrossRef PubMed
  23.  
  24. Petersen EW, Carey AL, Sacchetti M. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am. J. Physiol. Endocrinol. Metab. 2005; 288:155-62. CrossRef PubMed
  25.  
  26. Frankhauser S, Elias I, Sopakis VR. Overexpression of Il-6 leads to hyperinsulinemia, liver inflammation and reduced body weight in mice. Diabetol. 2008; 51:1306-16. CrossRef PubMed
  27.  
  28. Sugano M, Koga T, Yamada K. Lipids and immunology. Asia Pacific J Clin Nutr. 2000; 9: 146-52. CrossRef  
  29. Baumann H, Morella K K, White D W et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci. 1996; 93:8374-8. CrossRef PubMed PubMedCentral
  30.  

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.